Study no. BAY-86-4875/15962: Multicenter Open-Label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging(CMRI) for Detection of Significant Coronary Artery Disease(CAD) in Subjects with Known or Suspected CAD by a Blinded I

Project: Research project

Project Details

Effective start/end date8/12/138/31/16


  • Ecron Acunova GmbH (BAY-86-4875/15962 // BAY-86-4875/15962)
  • Bayer HealthCare Pharmaceuticals, Inc. (BAY-86-4875/15962 // BAY-86-4875/15962)